These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 28558333

  • 1. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
    Bao N, Ou J, Xu M, Guan F, Shi W, Sun J, Chen L.
    Eur J Med Chem; 2017 Sep 08; 137():88-95. PubMed ID: 28558333
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition.
    Li N, Ou J, Bao N, Chen C, Shi Z, Chen L, Sun J.
    Bioorg Chem; 2020 Nov 08; 104():104208. PubMed ID: 32919131
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives.
    Li H, Wang K, Wan Q, Chen Y.
    Steroids; 2019 Jan 08; 141():81-95. PubMed ID: 30521816
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents.
    Huang G, Zhao HR, Meng QQ, Zhang QJ, Dong JY, Zhu BQ, Li SS.
    Eur J Med Chem; 2018 Jan 01; 143():166-181. PubMed ID: 29174813
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
    Mallavadhani UV, Prasad CV, Shrivastava S, Naidu VG.
    Eur J Med Chem; 2014 Aug 18; 83():84-91. PubMed ID: 24953027
    [Abstract] [Full Text] [Related]

  • 18. Novel quinoline derivatives carrying nitrones/oximes nitric oxide donors: Design, synthesis, antiproliferative and caspase-3 activation activities.
    Abdelbaset MS, Abdel-Aziz M, Abuo-Rahma GEA, Abdelrahman MH, Ramadan M, Youssif BGM.
    Arch Pharm (Weinheim); 2019 Jan 18; 352(1):e1800270. PubMed ID: 30500087
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
    Luo Y, Wu W, Zha D, Zhou W, Wang C, Huang J, Chen S, Yu L, Li Y, Huang Q, Zhang J, Zhang C.
    Bioorg Med Chem Lett; 2021 Sep 01; 47():128230. PubMed ID: 34186178
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives.
    Shanab K, Schirmer E, Knafl H, Wulz E, Holzer W, Spreitzer H, Schmidt P, Aicher B, Müller G, Günther E.
    Bioorg Med Chem Lett; 2010 Jul 01; 20(13):3950-2. PubMed ID: 20537894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.